MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Altered perceptual hand maps in focal hand dystonia

    T. Mainka, B. Ossmann, K. Zeuner, A. Baumann, T. Bäumer, A. Kühn, E. Azanon Gracia, S. Zittel, M. Longo, C. Ganos (Berlin, Germany)

    Objective: To assess implicit hand maps in patients with focal hand dystonia (FHD). Background: In FHD, changes in the perception of tactile stimuli are suggested…
  • MDS Virtual Congress 2020

    Time matters in brain health: how can health systems respond to the growing demand for genetic testing?

    A. Noyce, G. Giovannoni, P. Scheltens, D. Berg, L. Brown, K. Dierickx, G. Frisoni, J. Georges, J. Hardy, K. Heilbron (London, United Kingdom)

    Objective: The global burden of neurodegenerative disease is increasing and health systems are not yet equipped to manage large numbers of people who are at…
  • MDS Virtual Congress 2020

    Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes

    S. Hussain, A. Singh, H. Baxi, B. Taylor, J. Burgess, B. Antony (Delhi, India)

    Objective: This meta-analysis is aimed to explore the association between thiazolidinedione (TZD) use and Parkinson’s disease (PD) risk. Background: Recent epidemiological studies found protective effects of TZD class of drugs in…
  • MDS Virtual Congress 2020

    Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson´s disease in the United Kingdom

    L. Rutten-Jacobs, S. Roumpanis, Y. Liu, P. Coloma (Basel, Switzerland)

    Objective: To explore the association between prediagnostic symptoms and treatment initiation in people with Parkinson´s disease (PD) Background: Prediagnostic symptoms in people with PD may…
  • MDS Virtual Congress 2020

    Late onset Wilson’s disease with hepatic and neurological manifestations

    H.J Kim, D.W Kwack, S.H Kim (Seoul, Republic of Korea)

    Objective: To report a patient with clinically diagnosed late-onset Wilson’s disease (WD). Background: WD is an autosomal recessive disorder of copper biliary excretion caused by…
  • MDS Virtual Congress 2020

    Changes in fecal microbiota composition in patients with Huntington’s disease in China

    G. Du, W. Dong, Q. Yang, Y. Huang (Beijing, China)

    Objective: Gut-brain axis has been associated with multiple brain disorders [1,2,3]. This study is to explore fecal microbiota changes in Huntington's disease (HD). Background: Huntington's…
  • MDS Virtual Congress 2020

    Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate features of NMS in PwHD of Tomsk region. Background: Patients with Huntington's disease(PwHD) can complain of other non-motor symptoms(NMS)…
  • MDS Virtual Congress 2020

    Nomencladventure: Palatal myoclonus and palatal tremor

    D. Riley (Cleveland, OH, USA)

    Objective: To evaluate the appropriateness of the 1990 change in nomenclature from palatal myoclonus to palatal tremor, and the acceptance rate of the change in…
  • MDS Virtual Congress 2020

    Tau Neuropathology Associates with In Vivo Patterns of Neurodegeneration in Lewy Body Disorders

    N. Spotorno, D. Coughlin, L. Shaw, A. Chen-Plotkin, D. Weintraub, E. Lee, J. Trojanowski, C. McMillan, D. Irwin, M. Grossman (Philadelphia, PA, USA)

    Objective: Investigate the impact of Alzheimer’s disease (AD) co-pathology on an in vivo structural measure of neurodegeneration in Lewy Body disorders (LBD: Parkinson’s Disease and…
  • MDS Virtual Congress 2020

    Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders

    C.H Tai, S.H Tseng, T.R Wang, M.T Hsu, C-C. Kuo (Taipei, Taiwan)

    Objective: We test the hypothesis of modulating subthalamic neuronal firing pattern via injection of hyperpolarizing current as an effective treatment for hyperkinetic movement disorders. Background:…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley